Escobar Dávila, Santiago LeandroRivas Tafurt, Giovanna PatriciaMelo Burbano, Luis ÁlvaroOsorio Toro, Luis MiguelBenítez Escobar, Edith NorelaGalindes Casanova, Duván ArleyIzquierdo Loaiza, Jorge HernánCárdenas Perilla, Rodrigo AndrésOrozco De la Hoz, Carlos2025-07-102025-07-102024Escobar-Dávila, S. L., Rivas-Tafurt, G. P., Melo-Burbano, L. Á., Osorio-Toro, L. M., Benítez-Escobar, E. N., Galindes-Casanova, D. A., Izquierdo-Loaiza, J. H., Cárdenas-Perilla, R. A., & Orozco-De la Hoz, C. (2024). Report of Henoch-Schönlein purpura associated with trastuzumab emtansine. Ecancermedicalscience, 18. https://doi.org/10.3332/ecancer.2024.173217546605https://repositorio.usc.edu.co/handle/20.500.12421/7385Vasculitides are a set of pathologies that can affect one or several organs, in the short and long term. They are associated with various etiologies, among which paraneoplastic syndromes and medications stand out. Although everyday cancer therapies are more directed against a therapeutic target, their use can cause a wide spectrum of complications. Some treatments against human epidermal growth factor 2 (HER2) have been associated with cutaneous and pulmonary vasculitis. We present the first case of Henoch-Schönlein purpura associated with the use of T-DM1 in a patient with HER2 breast cancer.enHenoch-Schönlein purpuraparaneoplastic syndromevasculitisReport of Henoch-Schönlein purpura associated with trastuzumab emtansineArticle